ID   AOC1_HUMAN              Reviewed;         751 AA.
AC   P19801; C9J690; Q16683; Q16684; Q56II4; Q6GU42;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   07-JUL-2009, sequence version 4.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=Amiloride-sensitive amine oxidase [copper-containing];
DE            Short=DAO;
DE            Short=Diamine oxidase;
DE            EC=1.4.3.22 {ECO:0000269|PubMed:19764817};
DE   AltName: Full=Amiloride-binding protein 1;
DE   AltName: Full=Amine oxidase copper domain-containing protein 1;
DE   AltName: Full=Histaminase;
DE   AltName: Full=Kidney amine oxidase;
DE            Short=KAO;
DE   Flags: Precursor;
GN   Name=AOC1; Synonyms=ABP1, DAO1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANT
RP   ASP-645.
RC   TISSUE=Kidney;
RX   PubMed=2217167; DOI=10.1073/pnas.87.19.7347;
RA   Barbry P., Champe M., Chassande O., Munemitsu S., Champigny G.,
RA   Lingueglia E., Maes P., Frelin C., Tartar A., Ullrich A.,
RA   Lazdunski M.;
RT   "Human kidney amiloride-binding protein: cDNA structure and functional
RT   expression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:7347-7351(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8182053;
RA   Chassande O., Renard S., Barbry P., Lazdunski M.;
RT   "The human gene for diamine oxidase, an amiloride binding protein.
RT   Molecular cloning, sequencing, and characterization of the promoter.";
RL   J. Biol. Chem. 269:14484-14489(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANTS PHE-332
RP   AND ASP-645.
RC   TISSUE=Placenta;
RX   PubMed=8595053; DOI=10.1007/BF00553624;
RA   Zhang X., Kim J., McIntire W.S.;
RT   "cDNA sequences of variant forms of human placenta diamine oxidase.";
RL   Biochem. Genet. 33:261-268(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MET-16; PHE-332;
RP   ILE-479; ASP-645 AND HIS-659.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-645.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 20-39, AND CHARACTERIZATION.
RC   TISSUE=Placenta;
RX   PubMed=8144586;
RA   Novotny W.F., Chassande O., Baker M., Lazdunski M., Barbry P.;
RT   "Diamine oxidase is the amiloride-binding protein and is inhibited by
RT   amiloride analogues.";
RL   J. Biol. Chem. 269:9921-9925(1994).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 22-751 ALONE AND IN COMPLEX
RP   WITH CALCIUM; COPPER AND IHIBITORS, GLYCOSYLATION AT ASN-110; ASN-538
RP   AND ASN-745, ACTIVE SITE, CALCIUM-BINDING SITES, COPPER-BINDING SITES,
RP   DISULFIDE BONDS, TOPAQUINONE AT TYR-461, SUBUNIT, ENZYME REGULATION,
RP   AND CATALYTIC ACTIVITY.
RX   PubMed=19764817; DOI=10.1021/bi9014192;
RA   McGrath A.P., Hilmer K.M., Collyer C.A., Shepard E.M., Elmore B.O.,
RA   Brown D.E., Dooley D.M., Guss J.M.;
RT   "Structure and inhibition of human diamine oxidase.";
RL   Biochemistry 48:9810-9822(2009).
CC   -!- FUNCTION: Catalyzes the degradation of compounds such as
CC       putrescine, histamine, spermine, and spermidine, substances
CC       involved in allergic and immune responses, cell proliferation,
CC       tissue differentiation, tumor formation, and possibly apoptosis.
CC       Placental DAO is thought to play a role in the regulation of the
CC       female reproductive function.
CC   -!- CATALYTIC ACTIVITY: Histamine + H(2)O + O(2) = (imidazol-4-
CC       yl)acetaldehyde + NH(3) + H(2)O(2). {ECO:0000269|PubMed:19764817}.
CC   -!- COFACTOR:
CC       Name=Cu cation; Xref=ChEBI:CHEBI:23378;
CC         Evidence={ECO:0000269|PubMed:19764817};
CC       Note=Binds 1 copper ion per subunit.
CC       {ECO:0000269|PubMed:19764817};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:19764817};
CC       Note=Binds 2 calcium ions per subunit.
CC       {ECO:0000269|PubMed:19764817};
CC   -!- COFACTOR:
CC       Name=L-topaquinone; Xref=ChEBI:CHEBI:79027;
CC         Evidence={ECO:0000269|PubMed:19764817};
CC       Note=Contains 1 topaquinone per subunit.
CC       {ECO:0000269|PubMed:19764817};
CC   -!- ENZYME REGULATION: Inhibited by isoniazid, cimetidine, clonidine,
CC       pentamidine, berenil and pentamidine.
CC       {ECO:0000269|PubMed:19764817}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC       {ECO:0000269|PubMed:19764817}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P19801-1; Sequence=Displayed;
CC       Name=2; Synonyms=DAO2;
CC         IsoId=P19801-2; Sequence=VSP_055190;
CC         Note=Ref.3 (AAB60381) sequence is in conflict in position:
CC         632:A->R. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Placenta and kidney.
CC   -!- PTM: Topaquinone (TPQ) is generated by copper-dependent
CC       autoxidation of a specific tyrosyl residue.
CC       {ECO:0000250|UniProtKB:P12807}.
CC   -!- MISCELLANEOUS: Inhibited by amiloride in a competitive manner.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the copper/topaquinone oxidase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA58358.1; Type=Frameshift; Positions=266, 284, 328, 494, 497, 514, 707, 729; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/abp1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M55602; AAA58358.1; ALT_FRAME; mRNA.
DR   EMBL; X78212; CAA55046.1; -; Genomic_DNA.
DR   EMBL; U11862; AAC50270.1; -; mRNA.
DR   EMBL; U11863; AAB60381.1; -; mRNA.
DR   EMBL; AY948960; AAX81409.1; -; Genomic_DNA.
DR   EMBL; AC006343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006479; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014093; AAH14093.1; -; mRNA.
DR   CCDS; CCDS43679.1; -. [P19801-1]
DR   CCDS; CCDS64797.1; -. [P19801-2]
DR   PIR; A54053; A54053.
DR   RefSeq; NP_001082.2; NM_001091.3. [P19801-1]
DR   RefSeq; NP_001259001.1; NM_001272072.1. [P19801-2]
DR   RefSeq; XP_016867433.1; XM_017011944.1. [P19801-2]
DR   RefSeq; XP_016867434.1; XM_017011945.1. [P19801-2]
DR   RefSeq; XP_016867435.1; XM_017011946.1. [P19801-2]
DR   RefSeq; XP_016867436.1; XM_017011947.1. [P19801-1]
DR   UniGene; Hs.647097; -.
DR   UniGene; Hs.733889; -.
DR   PDB; 3HI7; X-ray; 1.80 A; A/B=21-751.
DR   PDB; 3HIG; X-ray; 2.09 A; A/B=21-751.
DR   PDB; 3HII; X-ray; 2.15 A; A/B=21-751.
DR   PDB; 3K5T; X-ray; 2.11 A; A=21-751.
DR   PDB; 3MPH; X-ray; 2.05 A; A/B=21-751.
DR   PDBsum; 3HI7; -.
DR   PDBsum; 3HIG; -.
DR   PDBsum; 3HII; -.
DR   PDBsum; 3K5T; -.
DR   PDBsum; 3MPH; -.
DR   ProteinModelPortal; P19801; -.
DR   SMR; P19801; -.
DR   BioGrid; 106544; 1.
DR   IntAct; P19801; 9.
DR   STRING; 9606.ENSP00000354193; -.
DR   BindingDB; P19801; -.
DR   ChEMBL; CHEMBL2118; -.
DR   DrugBank; DB00594; Amiloride.
DR   DrugBank; DB03608; Diminazene.
DR   iPTMnet; P19801; -.
DR   PhosphoSitePlus; P19801; -.
DR   DMDM; 251757489; -.
DR   PaxDb; P19801; -.
DR   PeptideAtlas; P19801; -.
DR   PRIDE; P19801; -.
DR   TopDownProteomics; P19801-1; -. [P19801-1]
DR   DNASU; 26; -.
DR   Ensembl; ENST00000360937; ENSP00000354193; ENSG00000002726. [P19801-1]
DR   Ensembl; ENST00000416793; ENSP00000411613; ENSG00000002726. [P19801-2]
DR   Ensembl; ENST00000467291; ENSP00000418328; ENSG00000002726. [P19801-1]
DR   Ensembl; ENST00000493429; ENSP00000418614; ENSG00000002726. [P19801-1]
DR   GeneID; 26; -.
DR   KEGG; hsa:26; -.
DR   UCSC; uc003whz.3; human. [P19801-1]
DR   CTD; 26; -.
DR   DisGeNET; 26; -.
DR   GeneCards; AOC1; -.
DR   H-InvDB; HIX0007216; -.
DR   HGNC; HGNC:80; AOC1.
DR   HPA; HPA031032; -.
DR   HPA; HPA031033; -.
DR   MIM; 104610; gene.
DR   neXtProt; NX_P19801; -.
DR   OpenTargets; ENSG00000002726; -.
DR   PharmGKB; PA24416; -.
DR   eggNOG; KOG1186; Eukaryota.
DR   eggNOG; COG3733; LUCA.
DR   GeneTree; ENSGT00510000046461; -.
DR   HOGENOM; HOG000233919; -.
DR   HOVERGEN; HBG004164; -.
DR   InParanoid; P19801; -.
DR   KO; K11182; -.
DR   OMA; FNSNFKG; -.
DR   OrthoDB; EOG091G0C1O; -.
DR   PhylomeDB; P19801; -.
DR   TreeFam; TF314750; -.
DR   BioCyc; MetaCyc:HS00083-MONOMER; -.
DR   BRENDA; 1.4.3.22; 2681.
DR   Reactome; R-HSA-211945; Phase 1 - Functionalization of compounds.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   EvolutionaryTrace; P19801; -.
DR   GenomeRNAi; 26; -.
DR   PRO; PR:P19801; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000002726; -.
DR   CleanEx; HS_ABP1; -.
DR   ExpressionAtlas; P19801; baseline and differential.
DR   Genevisible; P19801; HS.
DR   GO; GO:0005923; C:bicellular tight junction; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0005507; F:copper ion binding; IDA:UniProtKB.
DR   GO; GO:0052597; F:diamine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; IDA:UniProtKB.
DR   GO; GO:0052598; F:histamine oxidase activity; TAS:Reactome.
DR   GO; GO:0052599; F:methylputrescine oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008131; F:primary amine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0052600; F:propane-1,3-diamine oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0032403; F:protein complex binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0048038; F:quinone binding; IDA:UniProtKB.
DR   GO; GO:0004872; F:receptor activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0009308; P:amine metabolic process; IEA:InterPro.
DR   GO; GO:0097185; P:cellular response to azide; IDA:UniProtKB.
DR   GO; GO:0071280; P:cellular response to copper ion; IDA:UniProtKB.
DR   GO; GO:0035874; P:cellular response to copper ion starvation; IDA:UniProtKB.
DR   GO; GO:0071504; P:cellular response to heparin; TAS:UniProtKB.
DR   GO; GO:0071420; P:cellular response to histamine; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0046677; P:response to antibiotic; IDA:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IDA:UniProtKB.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 2.70.98.20; -; 1.
DR   InterPro; IPR000269; Cu_amine_oxidase.
DR   InterPro; IPR015798; Cu_amine_oxidase_C.
DR   InterPro; IPR016182; Cu_amine_oxidase_N-reg.
DR   InterPro; IPR015800; Cu_amine_oxidase_N2.
DR   InterPro; IPR015802; Cu_amine_oxidase_N3.
DR   PANTHER; PTHR10638; PTHR10638; 1.
DR   Pfam; PF01179; Cu_amine_oxid; 1.
DR   Pfam; PF02727; Cu_amine_oxidN2; 1.
DR   Pfam; PF02728; Cu_amine_oxidN3; 1.
DR   PRINTS; PR00766; CUDAOXIDASE.
DR   SUPFAM; SSF49998; SSF49998; 1.
DR   SUPFAM; SSF54416; SSF54416; 2.
DR   PROSITE; PS01164; COPPER_AMINE_OXID_1; 1.
DR   PROSITE; PS01165; COPPER_AMINE_OXID_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Complete proteome;
KW   Copper; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Heparin-binding; Metal-binding; Oxidoreductase; Polymorphism;
KW   Reference proteome; Secreted; Signal; TPQ.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:8144586}.
FT   CHAIN        20    751       Amiloride-sensitive amine oxidase
FT                                [copper-containing].
FT                                /FTId=PRO_0000035666.
FT   REGION      371    381       Substrate binding. {ECO:0000244|PDB:3HII,
FT                                ECO:0000269|PubMed:19764817}.
FT   REGION      458    463       Substrate binding. {ECO:0000244|PDB:3HII,
FT                                ECO:0000269|PubMed:19764817}.
FT   REGION      568    575       Heparin-binding. {ECO:0000250}.
FT   ACT_SITE    373    373       Proton acceptor.
FT                                {ECO:0000269|PubMed:19764817}.
FT   ACT_SITE    461    461       Schiff-base intermediate with substrate;
FT                                via topaquinone. {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       510    510       Copper; via tele nitrogen.
FT                                {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       512    512       Copper; via tele nitrogen.
FT                                {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       519    519       Calcium 1. {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       520    520       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       521    521       Calcium 1. {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       562    562       Calcium 2. {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       653    653       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       656    656       Calcium 2. {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       658    658       Calcium 2. {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       664    664       Calcium 1. {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       665    665       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   METAL       675    675       Copper; via pros nitrogen.
FT                                {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   MOD_RES     461    461       2',4',5'-topaquinone.
FT                                {ECO:0000269|PubMed:19764817}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   CARBOHYD    168    168       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    538    538       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   CARBOHYD    745    745       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000244|PDB:3K5T,
FT                                ECO:0000244|PDB:3MPH,
FT                                ECO:0000269|PubMed:19764817}.
FT   DISULFID    177    181       {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000269|PubMed:19764817}.
FT   DISULFID    391    417       {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000269|PubMed:19764817}.
FT   DISULFID    736    736       Interchain. {ECO:0000244|PDB:3HI7,
FT                                ECO:0000244|PDB:3HIG,
FT                                ECO:0000244|PDB:3HII,
FT                                ECO:0000269|PubMed:19764817}.
FT   VAR_SEQ     618    618       A -> ARTEGGQPRALSQAASPVPG (in isoform 2).
FT                                {ECO:0000303|PubMed:8595053}.
FT                                /FTId=VSP_055190.
FT   VARIANT      16     16       T -> M (in dbSNP:rs10156191).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_025078.
FT   VARIANT     332    332       S -> F (in dbSNP:rs1049742).
FT                                {ECO:0000269|PubMed:8595053,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_025079.
FT   VARIANT     479    479       M -> I (in dbSNP:rs45558339).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_025080.
FT   VARIANT     645    645       H -> D (in dbSNP:rs1049793).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2217167,
FT                                ECO:0000269|PubMed:8595053,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_007542.
FT   VARIANT     659    659       N -> H (in dbSNP:rs35070995).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_025081.
FT   CONFLICT     28     28       R -> A (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    280    280       P -> A (in Ref. 1; AAA58358).
FT                                {ECO:0000305}.
FT   CONFLICT    290    290       D -> T (in Ref. 1; AAA58358).
FT                                {ECO:0000305}.
FT   CONFLICT    572    572       K -> R (in Ref. 1; AAA58358).
FT                                {ECO:0000305}.
FT   CONFLICT    592    592       T -> S (in Ref. 1; AAA58358, 2; CAA55046,
FT                                3; AAC50270/AAB60381 and 6; AAH14093).
FT                                {ECO:0000305}.
FT   HELIX        29     33       {ECO:0000244|PDB:3HI7}.
FT   HELIX        38     49       {ECO:0000244|PDB:3HI7}.
FT   HELIX        52     54       {ECO:0000244|PDB:3HI7}.
FT   STRAND       64     75       {ECO:0000244|PDB:3HI7}.
FT   HELIX        79     88       {ECO:0000244|PDB:3HI7}.
FT   STRAND       96    103       {ECO:0000244|PDB:3HI7}.
FT   STRAND      105    108       {ECO:0000244|PDB:3HI7}.
FT   STRAND      110    117       {ECO:0000244|PDB:3HI7}.
FT   STRAND      119    121       {ECO:0000244|PDB:3HI7}.
FT   STRAND      124    129       {ECO:0000244|PDB:3HI7}.
FT   HELIX       137    140       {ECO:0000244|PDB:3HI7}.
FT   HELIX       145    158       {ECO:0000244|PDB:3HI7}.
FT   HELIX       160    162       {ECO:0000244|PDB:3HI7}.
FT   HELIX       163    170       {ECO:0000244|PDB:3HI7}.
FT   STRAND      173    176       {ECO:0000244|PDB:3HI7}.
FT   STRAND      178    186       {ECO:0000244|PDB:3HI7}.
FT   STRAND      191    193       {ECO:0000244|PDB:3HI7}.
FT   STRAND      198    205       {ECO:0000244|PDB:3HI7}.
FT   HELIX       210    212       {ECO:0000244|PDB:3HI7}.
FT   STRAND      214    222       {ECO:0000244|PDB:3HI7}.
FT   STRAND      225    227       {ECO:0000244|PDB:3HI7}.
FT   HELIX       228    230       {ECO:0000244|PDB:3HI7}.
FT   STRAND      232    238       {ECO:0000244|PDB:3HI7}.
FT   HELIX       246    254       {ECO:0000244|PDB:3HI7}.
FT   STRAND      301    303       {ECO:0000244|PDB:3HI7}.
FT   STRAND      309    313       {ECO:0000244|PDB:3HI7}.
FT   STRAND      316    320       {ECO:0000244|PDB:3HI7}.
FT   STRAND      322    329       {ECO:0000244|PDB:3HI7}.
FT   TURN        330    332       {ECO:0000244|PDB:3HI7}.
FT   STRAND      333    341       {ECO:0000244|PDB:3HI7}.
FT   STRAND      344    359       {ECO:0000244|PDB:3HI7}.
FT   HELIX       364    368       {ECO:0000244|PDB:3HI7}.
FT   STRAND      370    372       {ECO:0000244|PDB:3HI7}.
FT   HELIX       373    376       {ECO:0000244|PDB:3HI7}.
FT   HELIX       378    380       {ECO:0000244|PDB:3HI7}.
FT   TURN        387    389       {ECO:0000244|PDB:3HI7}.
FT   STRAND      395    405       {ECO:0000244|PDB:3HI7}.
FT   STRAND      410    422       {ECO:0000244|PDB:3HI7}.
FT   STRAND      427    433       {ECO:0000244|PDB:3HI7}.
FT   STRAND      435    445       {ECO:0000244|PDB:3HI7}.
FT   STRAND      448    456       {ECO:0000244|PDB:3HI7}.
FT   STRAND      458    469       {ECO:0000244|PDB:3HI7}.
FT   STRAND      475    483       {ECO:0000244|PDB:3HI7}.
FT   STRAND      487    489       {ECO:0000244|PDB:3HI7}.
FT   HELIX       492    496       {ECO:0000244|PDB:3HI7}.
FT   STRAND      497    502       {ECO:0000244|PDB:3HI7}.
FT   STRAND      505    508       {ECO:0000244|PDB:3HI7}.
FT   STRAND      510    520       {ECO:0000244|PDB:3HI7}.
FT   STRAND      524    540       {ECO:0000244|PDB:3HI7}.
FT   STRAND      547    559       {ECO:0000244|PDB:3HI7}.
FT   HELIX       562    565       {ECO:0000244|PDB:3HI7}.
FT   STRAND      569    571       {ECO:0000244|PDB:3MPH}.
FT   STRAND      575    584       {ECO:0000244|PDB:3HI7}.
FT   STRAND      590    598       {ECO:0000244|PDB:3HI7}.
FT   HELIX       610    619       {ECO:0000244|PDB:3HI7}.
FT   STRAND      621    626       {ECO:0000244|PDB:3HI7}.
FT   HELIX       629    631       {ECO:0000244|PDB:3HI7}.
FT   TURN        637    641       {ECO:0000244|PDB:3HI7}.
FT   STRAND      643    645       {ECO:0000244|PDB:3HI7}.
FT   HELIX       652    655       {ECO:0000244|PDB:3HI7}.
FT   STRAND      661    675       {ECO:0000244|PDB:3HI7}.
FT   HELIX       679    681       {ECO:0000244|PDB:3HI7}.
FT   STRAND      691    704       {ECO:0000244|PDB:3HI7}.
FT   HELIX       706    709       {ECO:0000244|PDB:3HI7}.
FT   STRAND      714    717       {ECO:0000244|PDB:3HI7}.
FT   STRAND      720    723       {ECO:0000244|PDB:3K5T}.
FT   STRAND      725    727       {ECO:0000244|PDB:3HI7}.
SQ   SEQUENCE   751 AA;  85378 MW;  37114CD0D446639C CRC64;
     MPALGWAVAA ILMLQTAMAE PSPGTLPRKA GVFSDLSNQE LKAVHSFLWS KKELRLQPSS
     TTTMAKNTVF LIEMLLPKKY HVLRFLDKGE RHPVREARAV IFFGDQEHPN VTEFAVGPLP
     GPCYMRALSP RPGYQSSWAS RPISTAEYAL LYHTLQEATK PLHQFFLNTT GFSFQDCHDR
     CLAFTDVAPR GVASGQRRSW LIIQRYVEGY FLHPTGLELL VDHGSTDAGH WAVEQVWYNG
     KFYGSPEELA RKYADGEVDV VVLEDPLPGG KGHDSTEEPP LFSSHKPRGD FPSPIHVSGP
     RLVQPHGPRF RLEGNAVLYG GWSFAFRLRS SSGLQVLNVH FGGERIAYEV SVQEAVALYG
     GHTPAGMQTK YLDVGWGLGS VTHELAPGID CPETATFLDT FHYYDADDPV HYPRALCLFE
     MPTGVPLRRH FNSNFKGGFN FYAGLKGQVL VLRTTSTVYN YDYIWDFIFY PNGVMEAKMH
     ATGYVHATFY TPEGLRHGTR LHTHLIGNIH THLVHYRVDL DVAGTKNSFQ TLQMKLENIT
     NPWSPRHRVV QPTLEQTQYS WERQAAFRFK RKLPKYLLFT SPQENPWGHK RTYRLQIHSM
     ADQVLPPGWQ EEQAITWARY PLAVTKYRES ELCSSSIYHQ NDPWHPPVVF EQFLHNNENI
     ENEDLVAWVT VGFLHIPHSE DIPNTATPGN SVGFLLRPFN FFPEDPSLAS RDTVIVWPRD
     NGPNYVQRWI PEDRDCSMPP PFSYNGTYRP V
//
